Generics Services
Reconfirm the price with seller
Services of other enterprises
Description
Since 1996, Novotech has been involved in bioequivalence testing and introduction of over 100 new generic formulations in Australia and New Zealand. With the advent of more complex biosimilar product development, Novotech is once again taking a leadership position in provide consulting and development advice to sponsors engaged in biosimilar development in the region. Through a process of engagement with key regulatory agencies, we are able to provide up to date regulatory advice and assist in product development planning for biosimilars intended for introduction anywhere in the world.
Contact the seller
Generics Services
We recommend to see